Restoring pluripotency using chemical compounds alone would be a major step forward in developing clinical grade pluripotent stem cells, but this has not yet been reported in human cells. We previously demonstrated that human amniocytes cultivated with valproic acid (VPA_AFS cells) acquired functional pluripotency whilst remaining distinct from embryonic stem (hES) cells, questioning the relationship between modulation of cell fate and molecular regulation of the pluripotency network. Here, we used single cell analysis and functional assays to reveal that VPA treatment resulted in a homogenous population of self-renewing non-transformed cells that fulfil hallmarks of pluripotency, i.e. a short G1 phase, a dependence on glycolytic metabolism, expression of epigenetic modifications on histones 3 and 4, and reactivation of endogenous OCT4 and downstream targets at a lower level than that observed in hES cells. Mechanistic insights into the process of VPA-induced reprogramming revealed that it was dependent on OCT4 promoter activation, which was achieved independently of the PI3K/AKT/mTOR pathway or GSK3 inhibition, but was concomitant with the presence of acetylated histones H3K9 and H3K56, which promote pluripotency. Our data identify for the first time the pluripotent transcriptional and molecular signature and metabolic status of human chemically-induced pluripotent stem cells. 
Introduction
The reprogramming of somatic cells to pluripotency was originally pioneered by forced expression of transcription factors (TFs) using retroviral transduction 1 . Alternative strategies have since been developed to minimise the number of TFs used 2 and to produce footprint-free induced pluripotent stem (iPS) cells without genomic alterations 3, 4 .
Ultimately, the complete replacement of ectopically expressed TFs by chemical (2) to find a target cell source which chromatin configuration is most permissive to such chemical treatments.
Paving the way for the generation of human CiPS cells, iPS cells have been generated from human fetal stem cells by ectopically expressing OCT4 alone 5, 6 . This suggests that stem cells present during early fetal development may be more amenable to reprogramming than terminally differentiated cells found in adult tissues. However, the accessibility of the cells is of paramount importance for developing autologous CiPS cells. Human amniocytes (amniotic fluid stem cells, i.e. AFS cells) are somatic fetal stem cells shed from the fetus in the amniotic fluid and isolated during mid-trimester amniocentesis 7 . Similar to other fetal mesenchymal stem cells (MSCs) 8 , AFS cells are multipotent and differentiate readily into bone, fat and cartilage. They are not 4 tumorigenic, present a low immunogenicity 9 , and maintain their phenotype and karyotype after cryopreservation and in vitro expansion, making them ideal candidates for translational use 7 . AFS cells are characterised by the expression of the standard MSC surface markers CD73, CD90 and CD105 10, 11 , along with SSEA4 and CD177. Whilst they are not pluripotent and do not express SOX2, NANOG, or OCT4A [12] [13] [14] 9 (the only isoform with a pivotal role in self-renewal and pluripotency 15 ), they present a higher degree of plasticity compared to adult MSCs, are more rapidly and efficiently reprogramed to pluripotency [16] [17] [18] , and are amenable to reprogramming using only OCT4 6 .
We previously reported in two independent studies that human amniocytes cultivated on
Matrigel in feeder-free hES cell conditions with the histone deacetylase inhibitor valproic acid (VPA, 2-propyl pentanoic acid) 19 , i.e. VPA_AFS cells, gained the capacity to form embryoid bodies (EBs) containing cells that expressed ectoderm (NESTIN, PAX6), primitive endoderm (BMP4), endoderm (CK3, CK19) and mesendoderm (GATA6) markers [11] [12] [13] . When injected subcutaneously into immunodeficient mice, VPA_AFS cells formed well-differentiated teratomas within 4-6 weeks, which contained derivatives of all three germ layers, as evidenced by immunostaining, i.e. ectoderm (-Tubulin, NESTIN, NR1), mesoderm (-ACTININ), and endoderm cells (SOX17, HNF-3, AFP) [11] [12] [13] . After
6-8 weeks of in vitro expansion in ESC conditions, VPA_AFS cells (but not AFS cells)
were capable of differentiating towards the definitive endoderm (CXCR4, SOX17 + and HNF-3 + , immunostaining) when cultured in serum-free conditions in the presence of Activin-A. When cultured in hepatocyte permissive medium, VPA_AFS cells (but not AFS cells) also differentiated into ALBUMIN + AFP + cells which produced urea. These 5 results show that compared to AFS cells, VPA_AFS cells have a higher developmental potential, and suggest that they have acquired functional pluripotency [11] [12] [13] .
However, genome-wide transcriptome analysis of the entire VPA_AFS cell population revealed that, despite being clearly separated from AFS cells, they remain different from hES cells [6] [7] [8] . This questions the relationship between cell potency and molecular state of the pluripotent network. To address this gap in knowledge, we used single cell analysis and a range of functional assays to comprehensively characterise VPA_AFS cells and understand how they relate to hES cells. We uncover for the first time that human amniocytes cultured in hES cell conditions and treated with VPA aquired some molecular, epigenetic and phenotypic features of pluripotency, and that the effect of VPA is OCT4A-dependent. We observed a reactivation of endogenous OCT4 and downstream targets in all individual VPA_AFS cells (albeit levels were not as high as those found in hES cells), resulting in a short cell cycle G1 phase and a dependence on glycolytic metabolism. Together, these data indicate that human amniocytes are a candidate cell source for developing chemical-based protocols to revert human cells to the naïve pluripotent state, which makes it easier to differentiate the cells into any cell type of interest. Because of this, naïve stem cells have application in regenerative medicine and for disease modelling.
RESULTS

6
VPA_AFS cells aquired functional pluripotency but are molecularly different from hES cells
The present study characterised the molecular state of the same three AFS cell samples which previously formed EBs and teratomas [11] [12] [13] . We first used the colony formation in soft agar assay to determine that VPA treatment did not induce the transformation of VPA_AFS cells, as evidenced by their inability to show anchorage-independent growth (Supplementary Figure 1a) .
Flow cytometry showed that the pluripotency-associated cell surface markers TRA-1-60, TRA-1-81 and SSEA3, and the nuclear TFs NANOG and OCT4A were expressed in hES cells was and absent in AFS cells but expressed in VPA_AFS cells, albeit plots showed overlapping tails with the isotype control for some of these proteins, which indicates the population is heterogeneous (Figure 1a) . However, scatter plot analysis of the whole population transcriptome showed that VPA_AFS cells were molecularly distinct from hES cells (r = 0.84), with the heatmap of pluripotency-associated genes showing lower expression levels in VPA_AFS cells (Figure 1b) .
VPA_AFS cells gained OCT4 and NANOG expression with high efficiency
As the results presented above were obtained on the whole population, it is possible that the low correlation (r = 0.84) between VPA_AFS cells and hES cells was due to the heterogeneity of the AFS cell population to reactivate endogenous OCT4 and NANOG. We next examined mitochondrial oxidative metabolism using carbon dioxide (  13 CO2) production as a marker, as 13 (Figure 3e ).
Together, these data indicated that VPA_AFS cells presented a higher dependance on glycolysis over OXPHOS, a feature associated with the pluripotent state in human and mouse cells 25, 26 .
Expression of markers associated with pluripotency in VPA_AFS cells
We used immunofluorescence-based staining to detect the expression of pluripotencyassociated proteins. We confirmed the flow cytometry results (Figure 1a) showing that endogenous OCT4 and NANOG proteins were expressed heterogeneously in VPA_AFS cells (Figure 4a ). 30 , suggesting that VPA treatment may influence miRNA biogenesis and cell fate.
VPA_AFS cells showed epigenetic modifications at histone 3 and 4
Modification of lysines on the tails of histones H3 and H4 plays an important role in the regulation of chromatin organisation and transcription 31 , and histone acetylation contributes to the maintenance of a pluripotent state, thereby improving the accessibility of DNA to transcriptional machinery required for transcription initiation 32 . Here, we
show that compared to AFS cells, VPA treatment induced acetylation at three histone H3 lysine residues, i.e. H3K9 ( 
NODAL, (4) undifferentiated embryonic cell transcription factor 1 UTF1, (5) GDF3, (6) forkhead box protein 3 FOXD3, and (7) telomerase reverse transcriptase TERT ( Figure   7 ).
However, developmental pluripotency associated 2 and 5 (DPPA2 and DPPA5), Krüppel-like Factor 2 (KLF2) and fibroblast growth factor 4 (FGF4), were not expressed in VPA_AFS cells (Figure 7) .
Single embryonic stem cell analysis revealed a gradient of expression of pluripotency genes in the hES cell population, with cells at the top of the hierarchy showing increased self-renewal and expressing TDGF-1 and GDF3 43 . We found that all the cells expressed TDGF-1, but only 72% of the cells expressed GDF3. It has also been shown that UTF1 is expressed in the few cells that become iPS cells, and hence can be used as an early marker to predict the ability of a cell to become fully reprogrammed 44 . Therefore, we investigated the proportion of cells that co-expressed GDF1 and UTF1 and found that 67% VPA_AFS cells co-expressed both genes (defined by a Ct value <35), with a subset of 30% cells showing higher levels of expression (Ct value < 25) (Figure 7) . We next investigated the molecular profile of the sub-population of cells co-expressing GDF3 and Figure 3a) . Figure 3b) , indicating that FOXD3+ cells, which represent 47% of the whole VPA_AFS cell population correspond to the highest expressing cells of the heterogeneous cluster of pluripotency associated transcripts.
Principle component analysis reveals the hierarchical organisation of VPA_AFS cells
Principle component analysis of the data 41 for the pluripotency-associated genes studied Figure 4) .
VPA-mediated OCT4 promoter activation occured independently of GSK3 or PI3K/AKT/mTOR signaling
VPA has previously show to enhance OCT4 promoter activity through activation of the PI3K/AKT/mTOR signalling pathway activated nuclear receptors in mouse myogenic cells [58] [59] . Therefore, to gain mechanistic insight into the process of VPA reprogramming, we examined whether the same mechanisms was operating in VPA-AFS cells. However, treatment of AFS cells with 1mM VPA for 2 or 24 hours did not affect the levels of phospho-AKT or phospho-mTOR (Supplementary Figure 5a) , indicating that activation of the PI3K/AKT/mTOR signalling pathway is not required for VPA to mediate OCT4 activation and revert human AFS cells to pluripotency.
VPA has pleiotropic effects which involve various pathways and multiple molecular targets such as glycogen synthase kinase 3 (GSK3) 59 . Here, we show that VPA treatment induced GSK3 inhibition in AFS cells, which could be recapitulated by treating AFS cells with the GSK3 inhibitor CHIR99021 (Supplementary Figure 5b) .
However, treatment of AFS cells with CHIR99021 alone failed to revert the cells to pluripotency, indicating that the primary target of VPA in AFS cells is not GSK3 (Supplementary Figure 5c) .
DISCUSSION
Here, we established a correlation between the molecular regulation of the pluripotent state in human amniocytes cultured in hES cell conditions supplemented with VPA, and a description based on chromatin modifications, metabolism, cell cyle and gene expression to understand the molecular quality behind the behaviour of pluripotency.
AFS cells, whose multipotent differentiation ability is routinely maintained in standard MSC cultured conditions, were adapted to feeder-free hES cell culture conditions before being treated with the histone deacetylase inhibitor VPA for 5-10 days, after which VPA_AFS cells were subsequently expanded for up to 30 days in feeder-free hES cell conditions. Short-term treatment with VPA reactivated the expression of endogenous 56 , and promoting cell cycle progression and glycolysis 57 . Interestingly, VPA also enhances OCT4 promoter activity through the activation of the PI3K/Akt/mTOR signaling pathway in mouse myogenic cells 58, 59 . It has also been established that mTOR complex 1 (mTORC1) signaling regulates histone H3K acetylation on lysine-56 [60] [61] [62] to promote nucleosome disassembly at promoter regions of OCT4 34 . However, we found that in AFS cells, VPA did not activate OCT4 promoter through the PI3K/Akt/mTOR signaling pathway or Negative controls were IgG or IgM primary antibody-specific isotypes.
For confocal immuno-staining, the cells were fixed and stained as previously described 7 .
Fluorescence confocal laser scanning microscopy images were collected on a Leica TCS SP5 (X1000 PL APO oil objective) and transferred to Adobe Photoshop (Adobe 500 μl culture medium was transferred to a 12-ml glass tube (Exetainer, Labco, UK), and glacial acetic acid (100 μl) was injected through the septum to release 13 CO2 from bicarbonate. The filter paper was also removed and placed in a 12-ml glass tube, and CO2
was released by the addition of glacial acetic acid. 13 CO2/ 12 CO2 was measured in the gas phase via isotope ratio mass spectrometry. The ratio of 13 CO2 to 12 CO2 in bicarbonate is proportional to the quantity of oxidised glucose 48 .
Fluorescent evaluation of ATP dynamics:
One day prior to the experiment, AFS and VPA_AFS cells were seeded on 22 mm round borosilicate cover glasses and incubated at 37°C, 5% CO2, to reach a confluence of approximatively 40% at imaging. The adherence of VPA_AFS cells to the glass surface was facilitated by coating the cover glasses with Western blotting: Protein lysates were generated using standard lysis buffer (50 mM Housekeeping genes for normalisation were GAPDH and 18S. error bars are s.e.m. 
